AI assistant
Sending…
uniQure N.V. — Director's Dealing 2017
Jun 7, 2017
31312_dirs_2017-06-07_b46cf82b-2f89-4c0d-9a45-5d8e755e6daf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: uniQure N.V. (QURE)
CIK: 0001590560
Period of Report: 2017-06-05
Reporting Person: Zelenkofske Steven (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-06-05 | Ordinary Shares | A | 175000 | $0.00 | Acquired | 175000 | Direct |
More from uniQure N.V.
Interim / Quarterly Report
2026
May 5
Earnings Release
2026
May 5
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Annual Report
2026
Mar 2